IGFBP2表达评估idh突变的胶质瘤患者生存 （IGFBP2 expression predicts IDH-mutant glioma patient survival） ...

Let’s hear the thoughts of some of the world’s leading glioma experts on the data from the study A Multilingual Overview of the INDIGO Study Data (Presented by Clinical Experts in French ...

MGMT promoter methylation and IDH1 mutations have been important steps towards establishing a more precise classification system for gliomas, and it is likely that the main progress will come from ...

“Patients with grade two glioma who had IDH1 mutation treated with Vorasidenib doubled in terms of survival. And it’s a ...

It is therefore an excellent approach to determine the IDH mutation status of glioma patients preoperatively and to individualise treatment options.

IDH mutations are commonly seen in gliomas, accounting for somewhere between 50% and 81% of cases, according to figures from the US National Institutes of Health (NIH). Prasad added that it is ...

Low-grade gliomas are tumours that arise from the ... While patients can sometimes live with the tumours for years, those with IDH mutations tend to develop aggressive characteristics after ...

People think of cancer as a genetic disease…caused by mutations, typically. But there's also a lot of evidence that in ... Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature.

Abstract 4589. Komrokji RS, Ali NHA, Xie Z, et al. IDH-1 somatic mutations are more commonly observed among patients with comcomitant myelodysplastic syndromes (MDS) and autoimmune rheumatoid ...